Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Weight loss trial reports success for breast cancer patients at one year mark
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.
4.
Reversing the toxic relationship with high doses of chemotherapy in oncology.
5.
Glioblastoma cells can 'unstick' from their neighbors to become more deadly
1.
From Birthmarks to Tumors: The Science Behind Infantile Hemangioma
2.
Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment
3.
Tumor Evolution: Signaling, Plasticity, and Intratumor Heterogeneity in Cancer
4.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
5.
LncRNAs in Cancer: Shaping Tumor Progression & Paving New Paths for Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XIV
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation